POST CATARACT SURGERY WITH AND WITHOUT EYE DROPS
- Conditions
- Health Condition 1: H251- Age-related nuclear cataract
- Registration Number
- CTRI/2020/10/028260
- Lead Sponsor
- Aravind Eye Hospital and Postgraduate Institute of Ophthalmology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Other (Terminated)
- Sex
- Not specified
- Target Recruitment
- 0
1) Patients undergoing topical phacoemulsification with foldable IOL implantation 2) Senile cataract
3) Axial length of 20.5 to 25mm
4) Staying within 100 kms from base hospital and willing for follow up
1) Age <40 years
2) Diabetes Mellitus of more than 5 years or those with retinopathy
2) Uncontrolled systemic illness
3) Advanced cataract (BCVA 3/60 or less)
4) NSIV, Posterior polar, subluxated , traumatic, complicated and developmental cataract
5) Pregnant and lactating women
6) Patients with mental illness
7) Non visualization of fundus
8) CDR of 0.7 & more
9) IOP of 21 & above
10) Glaucoma 11) Family history of glaucoma 12) H/O steroid responsiveness 13) On systemic steroids for asthma, rheumatoid arthritis or other illness 14)Corneal diseasess 15) Associated ocular comorbidity (ARMD, pseudo exfoliation, small pupil (5mm or less), floppy iris, corneal opacity, macular scar, epiretinal membrane, retinal detachment, uveitis, shallow anterior chamber) 16)Any intraoperative complications (PCR , ZD , Nucleus drop, Vitreous loss)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Level of Anterior chamber inflammation <br/ ><br>2.Incidence of Cysteriod macular edema <br/ ><br>3.Incidence of raised intra oclular pressure, glaucoma due to steroids <br/ ><br>Timepoint: 9 months
- Secondary Outcome Measures
Name Time Method 1. Visual outcome <br/ ><br>2. Inflammation break through requiring topical steroidsTimepoint: 9 months